SLAS2014
18 January 2014 - 22 January 2014
SLAS2014 will feature an outstanding scientific program of 130 podium sessions, hundreds of posters, 17 short courses, exhibitor tutorials, and satellite symposia. The seven educational tracks include: Assay Development and Screening, Automation and High Throughput Technologies, Drug Target Biology, Micro/Nano Technologies, Bioanalytical Techniques, Informatics and Diagnostics & Biomarkers.
San Diego Convention Center, San Diego, CA, USA
http://www.slas2014.org/index.cfm
Pharmaceutical Microbiology
20 January 2014 - 21 January 2014
The conference will aim to focus on the regulatory aspect, with topics addressing preparations for auditing, what to expect during the inspection process, and how to rectify poor situations. There will also be considerable spotlight on novel rapid methods, case studies from the USA, their implementation, and the current regulatory view on methods. Among these hot topics, popular talks from last will return and examine sterility assessment, risk management, and contamination control.
Marriott Regents Park Hotel, London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/conference/pharmaceutical-microbiology
Social Media in the Pharmaceutical Industry
22 January 2014 - 23 January 2014
As social media becomes increasingly integrated into society, so does the ability to network with one another. Corporate marketing has become a discussion, with two way channels of communication. Companies are accurately targeting specific products at the most relevant markets, consumers are able to share experiences and discuss ideas, and the industry-consumer relationship is extended well beyond the point of sale.
With health at the top of any patient’s agenda the opportunity for pharma to utilise social media to provide personalised care is abundant and with mobile devices becoming increasingly prolific, this personal contact is fast becoming continuous. Media is no longer simply a tool for companies to broadcast their own message, but has transformed into a means in which pharma are able to provide round the clock care, through active monitoring and remote diagnosis.
Marriott Regents Park Hotel, London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/conference/social-media-in-the-pharmaceutical-industry
Pre-Filled Syringes
27 January 2014 - 28 January 2014
Pre-filled syringes are continuing to make huge roadways in the applications of new therapeutic drugs, there are a number of challenges that must be overcome. Formulation and drug interactions with container material, filling equipment and drug stability are consistent problems. Allow PFS 14' to show you how these challenges are overcome and provide a range of answers through case studies exactly how your PFS can operate at its full capability.
Marriott Regents Park Hotel, London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/conference/pre-filled-syringes
Oncology Biologics: Paradigm Shift in Cancer Treatment
28 January 2014 - 29 January 2014
This innovative event will focus on current innovations in oncology biologics as well as future drug development and novel treatment options.
This conference will discuss the advancement in a board variety of oncology biologics including:
•Immunotherapy and cancer vaccines
•Antibody-drug conjugates (mix of antibody + toxin – targeted delivery) to target tumors
•Immunoconjugates
•Anti-angiogenesis biologics
•Stem cell targeting biologics
•Novel biologics beyond antibodies
•Bispecific antibodies
•Oncology biologics enabling diagnostics technologies
•Personalized cancer treatment
Hyatt Boston Harbour, Boston, MA, USA
http://www.exlpharma.com/event-home/4414?mkt_tok=3RkMMJWWfF9wsRohvqzAZKXonjHpfsX%2F4%2BQkX7Hr08Yy0EZ5VunJEUWy2YECSsR0aPyQAgobGp5I5FEJQ7XYUqVyt6wKWg%3D%3D
Novel Immunotherapeutics Summit
29 January 2014 - 31 January 2014
The Summit includes four concurrent conferences, all of which will talk about complementary areas of the latest breakthroughs in the immunology field:
12th Cytokines & Inflammation
Researchers will join to discuss the latest advances in targeting cytokines and chemokines for therapeutic interventions, cytokines and metabolism, and cytokines signalling pathways. Hot topics such as innate lymphoid cells and homeostasis on mucosal tissues will also be covered.
6th Immunotherapeutics & Immunomonitoring
Leading experts will present about novel findings and developments in the constantly changing area of immunological assays and procedures. This meeting will cover recent advances in immunotherapy and how they relate to various immunotherapy modalities, specific cancers, cell subsets, animal models, and tumor microenvironment.
2nd Immunogenicity and Immunotoxicity
Delegates will learn will about ongoing research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins, and speakers will discuss the progress of the ongoing research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins.
Inaugural Innate Immunity
Come to learn more about discoveries in toll like receptors, inflammasome reactions, the role of the microbiome and non-pathogenic bacteria, and many more.
Wyndham San Diego Bayside, San Diego, CA, USA
http://www.gtcbio.com/conference/novel-immunotherapeutics-summit-overview?utm_source=immunosummit&utm_medium=website&utm_campaign=immunosummit
Cytokines & Inflammation Conference
29 January 2014 - 31 January 2014
Over the years, GTC’s Cytokines & Inflammation Conference has become an established meeting point for academic scientists, industry clinical developers, and government researchers to discuss complementary approaches in the field of cytokine biology. Our 12th annual meeting will take place January 29-31, 2014 in San Diego, CA, so mark your calendars and save the date!
We will have presentations that cover a wide breadth of the latest hot topics, such as the metabolism of immune cells, innate lymphoid cells, gamma delta T cells, IL-33, and many more. The meeting is one of four concurrent conferences in the Novel Immunotherapeutics Summit, which features Nobel Laureate Jules A. Hoffmann as one of its keynote speakers.
Wyndham San Diego Bayside, San Diego, CA, USA
https://www.gtcbio.com/conference/cyto-overview?utm_source=cyto_conference&utm_medium=website&utm_content=cyto+overview&utm_campaign=conference+listing
SAN2014 Meeting
30 January 2014 - 02 February 2014
It is our great pleasure to welcome you to the conference website of the 2014 Meeting of the Society of Applied Neurosciences (SAN), jointly organized with the National Initiative Brain and Cognition (NIHC). The conference will be held from January 30th to February 2nd, 2014 in the Royal Dutch Jaarbeurs in Utrecht (The Netherlands).
Confirmed keynote speakers include Niels Birbaumer, John Gruzelier, Pascal Fries, Katya Rubia and Thomas Schlaepfer. Further keynote and invited speakers will be announced later.
Royal Dutch Jaarbeurs, Utrecht, Netherlands
http://applied-neuroscience.org/index.php/san2014/home
Reducing Attrition through Early Assessment of Drug Safety
13 March 2014
Drug toxicity remains one of the main causes of compound attrition in the drug development process. Compounds displaying organ, mechanism-based or off-target toxicity are just some of the safety issues that have contributed to drug development failures, and the need for robust early drug safety screening in an integrative manner is clear.
In the last decade, an increased understanding of the molecular basis for some of these toxicities and the advancement of technologies designed to screen for them has improved options for screening out potential compound liabilities earlier in the research phase. Advances include the use of human induced pluripotent stem cells and miniaturised mimics of human organs. New markers of toxicity are being investigated at the RNA level, using metabolomics and through application of bioinformatic approaches. In addition, technologies have been developed to gather data on broad compound promiscuity at the protein level using panels of off-target activity as markers of general promiscuity.
This meeting will bring together a range of international experts from both industry and academia to present the new technologies and their applications in early drug safety assessment. The meeting will be of great interest to anyone involved in drug discovery and development, or has an interest in the science behind drug safety screening
The National Heart and Lung Institute, Kensington, London, UK
https://www.smr.org.uk/smr/Meetings/20140313/default.asp
Biochemical Journal Symposium 2014: Human Therapeutics: Where Biology Meets Chemistry
20 March 2014
Following on from the Biochemical Journal's two highly successful one-day Symposia, this third Symposium is centred on drug discovery in academia - an area which is growing rapidly. This timely meeting, featuring twelve expert speakers in their respective fields, will focus on the use of chemical biology to foster drug discovery in the academic environment.
Holiday Inn Bloomsbury, London, UK
http://www.biochemj.org/symposium14/
Regulatory challenges and opportunities in antibiotic drug development and registration
08 April 2014
Much is happening globally in the world of antibiotic research, development, licencing and use. The paucity of new antibiotics for the effective treatment of multidrug gram negative infections over the last 10 years coupled with the inexorable rise of these organisms has led to claims for a disaster soon to happen. This has been likened to the global effects of climate change but this bacterial threat is already causing increased morbidity and mortality. Many proposals have been made by a large number of stakeholders including researchers, developers, regulatory bodies and payers recently.
This masterclass will deal with issues related to the opposing forces of investment, research and development when constructing a commercial forecast for a novel agent.
tbc London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/masterclass/regulatory-challenges-and-opportunities-in-antibiotic-drug-development-and-registration?utm_source=MC353&utm_medium=EM%20-%20MM&utm_campaign=GroupMail
Can the NHS afford to not fund innovative medicines?
06 May 2014
The meeting will set out the balances and checks on the approval of innovative medicines for use in the NHS, and debate whether the pendulum has now swung too far in favour of cost alone.
Royal Society Of Medicine, 1 Wimpole Street, LONDON, UK
http://www.rsm.ac.uk/academ/pme01.php
Frontiers in prescribing: Drug interactions: 50 years of progress
07 May 2014
Learning aims of the meeting:
To inform the audience on epidemiology, mechanisms and clinical consequences of drug-drug interactions in the modern therapeutic world.
Royal Society Of Medicine, 1 Wimpole Street, LONDON, UK
http://www.rsm.ac.uk/academ/rpe15.php
Creativity, music and the brain: The power of music over the mind
13 May 2014
The conference will appeal to those who want to learn more about the power of music on the brain, especially the effects of music on individuals, as well as its role in society. The conference will be suitable for psychiatrists, neurologists, psychologists, musicians and doctors; and for those who wish to learn more about creativity, music and the brain.
Royal Society Of Medicine, 1 Wimpole Street, London, UK
http://www.rsm.ac.uk/academ/pye05.php
10th European Functional Drug Screening Symposium
12 June 2014
This annual event is an opportunity to gain a greater insight and understanding of Drug Screening systems and recent advances. You can also meet with users of the Hamamatsu Photonics FDSS Drug Screening Systems, share experiences, successes and discuss ideas.. There is an exciting line up of guest speakers who will present some very interesting topics including Cell based assays, Novel screening methodologies and more. We are delighted to announce that this year's meeting will be held at Actelion Pharmaceuticals Ltd in Allschwil, Switzerland and this event is free to register.
Actelion Pharmaceuticals Ltd., Allschwill, Switzerland
http://www.hamamatsu.com/jp/en/community/fdss/Meetings/Users.html
Robotics and Automation 2014
01 July 2014
FESTO Applied Automation UK headquarters, Northampton is the setting for the 1 Day – ELRIG - Robotics & Automation show being held on 1st July.
The show will be focusing on the components and technologies used in laboratory automation applications.
It will be an opportunity to listen and discuss the implementation of automation components with colleagues and suppliers. A varied selection of full length and snapshot talks will be presented to give scientific and engineering users an understanding of what is available to automate experiments.
This conference is aimed at anyone who works in the life sciences laboratory environment and who would benefit from the implementation of these technologies. We intend to cover innovative technologies such as software for the automated process (control & data), robotic and process simulation and automation tools (vision and transportation).
FESTO Applied Automation UK headquarters, Northampton
http://www.elrig.org